The landscape of diabetes care is advancing with the introduction of GLP-1 patches . These novel patches offer a potentially less invasive alternative to shots for individuals dealing with diabetes mellitus type 2 . Such a system deliver a GLP-1 agonist directly through the dermis , bypassing the need for daily injections and potentially improving